Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Services » Servicestothe Health Industry
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| LH | Laboratory Corp. of America Holdings | -0.58% | 276.19 | 2.4% | $240.05m | |
| IQV | IQVIA Holdings, Inc. | -1.84% | 247.44 | 0.0% | $195.61m | |
| DGX | Quest Diagnostics, Inc. | -1.89% | 142.27 | 4.7% | $159.37m | |
| AMEH | Apollo Medical Holdings, Inc. | -1.13% | 60.35 | 0.0% | $25.79m | |
| NOTV | Inotiv, Inc. | 2.18% | 32.86 | 0.0% | $6.64m | |
| NRC | National Research Corp. | -1.16% | 38.21 | 0.0% | $1.58m | |
| PLX | Protalix Biotherapeutics, Inc. | -3.96% | 0.85 | 18.5% | $0.44m | |
| QIPT | Quipt Home Medical Corp. | -2.08% | 5.65 | 0.0% | $0.27m | |
| PMD | Psychemedics Corp. | 0.70% | 7.17 | 0.7% | $0.14m |
Company Profile
Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.